Suppliers / Rosemont Pharmaceuticals

Rosemont Pharmaceuticals

United Kingdom 300 employees Updated 9 July 2026

Rosemont Pharmaceuticals is a finished-dose manufacturer based in United Kingdom. It appears in 242 regulatory filings across 8 regulators, without an active US DMF or CEP on file. Its filings concentrate with MHRA (UK), EMA and DMP (NO). Its GMP standing is certified by MHRA (UK). Its most recent recorded inspection, by US FDA, closed on 8 February 2019 as VAI.

0
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
242
filings across 8 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
3 of 3 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 8 February 2019 VAI US FDA
  • 12 December 2014 VAI US FDA
  • 13 October 2011 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
LEEDS, United Kingdom Not on file
United Kingdom, United Kingdom 3002442738

Filings and GMP by regulator

Regulator Filings GMP certificates
MHRA (UK) 128 5
EMA 85 None
DMP (NO) 13 None
MPA (SE) 6 None
US FDA 4 None
SFDA (Saudi Arabia) 3 None

Questions about Rosemont Pharmaceuticals

Does Rosemont Pharmaceuticals hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Rosemont Pharmaceuticals. It does have 242 filings with 8 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Rosemont Pharmaceuticals FDA-registered?
One site operated by Rosemont Pharmaceuticals carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Rosemont Pharmaceuticals's last inspection go?
The most recent inspection on record closed on 8 February 2019 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 3 inspections are on file.
Where does Rosemont Pharmaceuticals manufacture?
2 registered sites are on record, in United Kingdom (Leeds and United Kingdom). Every site is listed on this page with the register it came from.
Which regulators recognise Rosemont Pharmaceuticals's GMP?
Current GMP certificates are on record from MHRA (UK). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Rosemont Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 8 February 2019.

Comparable suppliers

ALMAC Pharma Services also in United Kingdom Almac Sciences also in United Kingdom AstraZeneca UK also in United Kingdom Bard Pharmaceuticals also in United Kingdom Bell, Sons & Co (Druggists) also in United Kingdom

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates